Recombinant CD79B (Iladatuzumab Biosimilar) antibody

Catalog No. ABIN7597741

The Humanized Chimeric anti-CD79B (Iladatuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect CD79B (Iladatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD79B (Iladatuzumab Biosimilar) antibody (ABIN7597741)

Target: CD79B (Iladatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD79B (Iladatuzumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD79B (Iladatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Iladatuzumab Biosimilar Antibody

Specificity: B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.42 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD79B (Iladatuzumab Biosimilar)

Target: CD79B (Iladatuzumab Biosimilar)

Alternative Name: Iladatuzumab Biosimilar

Target Type: Biosimilar

Background: B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b

UniProt: P40259

CAS-No: 1906205-76-2